vs
Side-by-side financial comparison of PATHWARD FINANCIAL, INC. (CASH) and COLLEGIUM PHARMACEUTICAL, INC (COLL). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $173.1M, roughly 1.2× PATHWARD FINANCIAL, INC.). PATHWARD FINANCIAL, INC. runs the higher net margin — 20.3% vs 8.3%, a 12.1% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -0.2%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $104.1M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -18.0%).
Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
CASH vs COLL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $173.1M | $205.4M |
| Net Profit | $35.2M | $17.0M |
| Gross Margin | — | 62.5% |
| Operating Margin | 24.6% | 29.6% |
| Net Margin | 20.3% | 8.3% |
| Revenue YoY | -0.2% | 12.9% |
| Net Profit YoY | 11.9% | 35.3% |
| EPS (diluted) | $1.57 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $173.1M | $205.4M | ||
| Q3 25 | $186.7M | $209.4M | ||
| Q2 25 | $195.8M | $188.0M | ||
| Q1 25 | $274.8M | $177.8M | ||
| Q4 24 | $182.6M | $181.9M | ||
| Q3 24 | $179.5M | $159.3M | ||
| Q2 24 | $188.6M | $145.3M | ||
| Q1 24 | $257.6M | $144.9M |
| Q4 25 | $35.2M | $17.0M | ||
| Q3 25 | $38.8M | $31.5M | ||
| Q2 25 | $42.1M | $12.0M | ||
| Q1 25 | $75.0M | $2.4M | ||
| Q4 24 | $30.0M | $12.5M | ||
| Q3 24 | $33.5M | $9.3M | ||
| Q2 24 | $44.9M | $19.6M | ||
| Q1 24 | $69.9M | $27.7M |
| Q4 25 | — | 62.5% | ||
| Q3 25 | — | 61.7% | ||
| Q2 25 | — | 57.7% | ||
| Q1 25 | — | 54.8% | ||
| Q4 24 | — | 54.0% | ||
| Q3 24 | — | 60.8% | ||
| Q2 24 | — | 62.5% | ||
| Q1 24 | — | 63.1% |
| Q4 25 | 24.6% | 29.6% | ||
| Q3 25 | 25.9% | 29.7% | ||
| Q2 25 | 24.1% | 18.7% | ||
| Q1 25 | 33.2% | 12.2% | ||
| Q4 24 | 19.8% | 20.9% | ||
| Q3 24 | 20.9% | 21.9% | ||
| Q2 24 | 27.1% | 32.7% | ||
| Q1 24 | 33.8% | 34.1% |
| Q4 25 | 20.3% | 8.3% | ||
| Q3 25 | 20.8% | 15.0% | ||
| Q2 25 | 21.5% | 6.4% | ||
| Q1 25 | 27.3% | 1.4% | ||
| Q4 24 | 16.4% | 6.9% | ||
| Q3 24 | 18.7% | 5.9% | ||
| Q2 24 | 23.8% | 13.5% | ||
| Q1 24 | 27.1% | 19.1% |
| Q4 25 | $1.57 | $0.48 | ||
| Q3 25 | $1.69 | $0.84 | ||
| Q2 25 | $1.81 | $0.34 | ||
| Q1 25 | $3.14 | $0.07 | ||
| Q4 24 | $1.23 | $0.36 | ||
| Q3 24 | $1.34 | $0.27 | ||
| Q2 24 | $1.78 | $0.52 | ||
| Q1 24 | $2.74 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $331.2M | $386.7M |
| Total DebtLower is stronger | $33.5M | — |
| Stockholders' EquityBook value | $854.5M | $301.7M |
| Total Assets | $7.6B | $1.7B |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $331.2M | $386.7M | ||
| Q3 25 | $120.6M | $285.9M | ||
| Q2 25 | $258.3M | $222.2M | ||
| Q1 25 | $254.2M | $197.8M | ||
| Q4 24 | $597.4M | $162.8M | ||
| Q3 24 | $158.3M | $120.0M | ||
| Q2 24 | $298.9M | $271.6M | ||
| Q1 24 | $347.9M | $318.0M |
| Q4 25 | $33.5M | — | ||
| Q3 25 | $33.5M | — | ||
| Q2 25 | $33.4M | — | ||
| Q1 25 | $33.4M | — | ||
| Q4 24 | $33.4M | — | ||
| Q3 24 | $33.4M | — | ||
| Q2 24 | $33.3M | — | ||
| Q1 24 | $33.4M | — |
| Q4 25 | $854.5M | $301.7M | ||
| Q3 25 | $858.0M | $274.8M | ||
| Q2 25 | $819.0M | $232.2M | ||
| Q1 25 | $814.7M | $234.4M | ||
| Q4 24 | $758.3M | $228.8M | ||
| Q3 24 | $822.5M | $234.3M | ||
| Q2 24 | $748.4M | $216.6M | ||
| Q1 24 | $719.5M | $222.2M |
| Q4 25 | $7.6B | $1.7B | ||
| Q3 25 | $7.2B | $1.6B | ||
| Q2 25 | $7.2B | $1.6B | ||
| Q1 25 | $7.0B | $1.6B | ||
| Q4 24 | $7.6B | $1.7B | ||
| Q3 24 | $7.5B | $1.6B | ||
| Q2 24 | $7.5B | $1.1B | ||
| Q1 24 | $7.4B | $1.1B |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.04× | — | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.04× | — | ||
| Q1 24 | 0.05× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $108.3M | $123.0M |
| Free Cash FlowOCF − Capex | $104.1M | $122.4M |
| FCF MarginFCF / Revenue | 60.1% | 59.6% |
| Capex IntensityCapex / Revenue | 2.4% | 0.3% |
| Cash ConversionOCF / Net Profit | 3.08× | 7.25× |
| TTM Free Cash FlowTrailing 4 quarters | $616.8M | $327.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.3M | $123.0M | ||
| Q3 25 | $303.7M | $78.4M | ||
| Q2 25 | $30.4M | $72.4M | ||
| Q1 25 | $188.3M | $55.4M | ||
| Q4 24 | $-71.7M | $84.6M | ||
| Q3 24 | $143.1M | $-9.0M | ||
| Q2 24 | $113.2M | $67.4M | ||
| Q1 24 | $203.0M | $61.9M |
| Q4 25 | $104.1M | $122.4M | ||
| Q3 25 | $300.3M | $78.3M | ||
| Q2 25 | $27.7M | $72.4M | ||
| Q1 25 | $184.7M | $54.6M | ||
| Q4 24 | $-73.8M | $84.1M | ||
| Q3 24 | $138.8M | $-9.2M | ||
| Q2 24 | $111.0M | $67.1M | ||
| Q1 24 | $201.3M | $61.4M |
| Q4 25 | 60.1% | 59.6% | ||
| Q3 25 | 160.9% | 37.4% | ||
| Q2 25 | 14.1% | 38.5% | ||
| Q1 25 | 67.2% | 30.7% | ||
| Q4 24 | -40.4% | 46.2% | ||
| Q3 24 | 77.3% | -5.8% | ||
| Q2 24 | 58.8% | 46.2% | ||
| Q1 24 | 78.1% | 42.3% |
| Q4 25 | 2.4% | 0.3% | ||
| Q3 25 | 1.8% | 0.1% | ||
| Q2 25 | 1.4% | 0.0% | ||
| Q1 25 | 1.3% | 0.4% | ||
| Q4 24 | 1.1% | 0.3% | ||
| Q3 24 | 2.4% | 0.2% | ||
| Q2 24 | 1.2% | 0.2% | ||
| Q1 24 | 0.7% | 0.4% |
| Q4 25 | 3.08× | 7.25× | ||
| Q3 25 | 7.83× | 2.49× | ||
| Q2 25 | 0.72× | 6.05× | ||
| Q1 25 | 2.51× | 22.92× | ||
| Q4 24 | -2.39× | 6.75× | ||
| Q3 24 | 4.27× | -0.96× | ||
| Q2 24 | 2.52× | 3.44× | ||
| Q1 24 | 2.90× | 2.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CASH
| Consumer | $103.0M | 59% |
| Payment Card And Deposit Fees | $30.1M | 17% |
| Other | $24.2M | 14% |
| Rental Income | $11.6M | 7% |
| Commercial | $4.2M | 2% |
COLL
Segment breakdown not available.
